Latest Articles
-
Five for Friday March 14: Celebrating Success in Advancing Medication Use Quality
In 2023, PQA launched a multiphase national medication therapy management (MTM) initiative to address stakeholder needs and advance MTM quality measurement. PQA has identified six objectives that can advance MTM quality and measurement, and the MTM Advisory Group is serving as a forum providing expert feedback on how to approach these. As a first step, the PQA […] -
Prioritizing Access to Care and Health Equity at PQA
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications. As we work to address health equity and social determinants of health that affect medication use quality and patient outcomes, we believe that a diverse, equitable and inclusive workforce will strengthen […] -
Five for Friday February 28: Celebrating Success in Advancing Medication Use Quality
PQA is now accepting self-nominations for the Diversity in Quality Scholarship. The program provides scholarships for health care professional students to attend the 2025 PQA Annual Meeting, May 19-21, in Tampa, Fla., and participate in the pre-meeting Medication Use Quality Live workshop on May 19. This scholarship opportunity is part of the PQA Diverse Quality Leaders Program and our commitment to build a […] -
Evaluating the Medication Therapy Management Program Using the Andersen Behavioral Model
The Medicare Part D medication therapy management (MTM) program aims to optimize therapeutic outcomes and reduce the risk of adverse events and associated costs by identifying and addressing medication therapy problems. There are specific eligibility criteria for Medicare beneficiaries to take advantage of these services. However, a significant portion of those eligible do not choose […] -
Five for Friday February 14: Celebrating Success in Advancing Medication Use Quality
Join us as we head to the Sunshine State for the 2025 PQA Annual Meeting, May 19-21! Meeting registration and hotel reservations are now open—don’t miss your chance to participate! Make your plans to join us and other quality professionals in Tampa at the primer event for quality medication use. Enhance the impact of your attendance by becoming a sponsor […] -
Patients’ Experience with Comprehensive Medication Reviews
PQA and research partners at the University of Arizona, the University of Health Sciences and Pharmacy in St. Louis, and Merck & Co. recently conducted patient interviews to explore patients’ perceptions of their experience with comprehensive medication reviews (CMR). This work was published in the December 2024 issue of the Journal of Managed Care & […] -
Five for Friday January 31: Celebrating Success in Advancing Medication Use Quality
PQA has published a new report that summarizes the conversations from PQA Convenes: Quality Medication Use in Rare Disease, held on November 7, which brought together health care quality experts, rare disease leaders and individuals with lived experience to discuss what constitutes high-quality rare disease medication use. This report compiles perspectives shared over four discussion panels. Several […] -
Use of PQA’s SDOH Resource Guide to Address Barriers in Patients’ Medication Access Journey
Barriers to medication access are a public health issue that affect adherence and patient outcomes. PQA emphasizes the pharmacist’s role in medication access and developed the Medication Access Patient Journey (MAPJ) conceptual framework that defines a patient’s medication access journey and characterizes barriers frequently encountered while seeking medication access. This framework highlights seven steps, or […] -
Pharmacy Quality Alliance Elects 2025 Board of Directors and Executive Committee
Four New Members from Diverse Health Care Professions, Organizations and Industries Join Board Alexandria, Va. (January 27, 2025) – The Pharmacy Quality Alliance (PQA) Board of Directors elected four new members and its 2025 executive committee officers during the 2024 fourth quarter meeting. Individuals began serving their 2025 term on January 1. “PQA’s Board of Directors is […] -
PQA Releases Report to Define Quality Medication Use for Rare Diseases
PQA In the News
-
Making Medication Management Services Measurable and Visible
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality

“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Stay Informed
Get the latest PQA news and events delivered to your inbox.


